Ignite Creation Date:
2025-12-26 @ 10:16 PM
Ignite Modification Date:
2026-03-08 @ 11:20 PM
Study NCT ID:
NCT02396212
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2015-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-25
First Submit QC Date:
None
Study First Post Date:
2015-03-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-01-30
Results First Submit QC Date:
None
Results First Post Date:
2019-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-07
Last Update Post Date:
2019-09-13
Last Update Post Date Type:
ACTUAL